Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
European Archives of Oto-Rhino-Laryngology
Erschienen in: European Archives of Oto-Rhino-Laryngology 2/2016

01.02.2016 | Review Article

The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck

verfasst von: Małgorzata Wierzbicka, Anna Bartochowska, Vratislav Strnad, Primož Strojan, William M. Mendenhall, Louis B. Harrison, Alessandra Rinaldo, Puja Sahai, Susanne Wiegand, Alfio Ferlito

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Brachytherapy is a form of intensive local irradiation, allowing effective protection of surrounding structures with preservation of organ function and results in a favorable therapeutic ratio. It can be used alone, adjuvantly after surgery, and as a local boost in combination with external-beam radiation therapy. This paper is a literature review on the role of brachytherapy in the management of head and neck cancers with a special emphasis on papers published in the last 5 years. Technical details, effectiveness and potential toxicities of brachytherapy when used in different combinations with other therapeutic modalities and tumor sites are presented. Brachytherapy is an attractive treatment option in the management of primary malignancies and recurrent tumors in previously irradiated areas of the head and neck. It is effective and safe, and results in good functional and oncological outcomes.
Literatur
1.
Mazeron JJ, Ardiet JM, Haie-Méder C et al (2009) GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas. Radiother Oncol 91:150–156PubMedCrossRef
2.
3.
Strnad V, Lotter M, Kreppner S et al (2013) Interstitial pulsed-dose-rate brachytherapy for head and neck cancer—single-institution long-term results of 385 patients. Brachytherapy 12:521–527PubMedCrossRef
4.
Nag S, Cano ER, Demanes DJ et al (2001) The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 50:1190–1198PubMedCrossRef
5.
Khalilur R, Hayashi K, Shibuya H (2011) Brachytherapy for tongue cancer in the very elderly is an alternative to external beam radiation. Br J Radiol 84:747–749PubMedPubMedCentralCrossRef
6.
Yamazaki H, Yoshida K, Kotsuma T et al (2010) Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older. Radiat Oncol 5:116PubMedPubMedCentralCrossRef
7.
Yamazaki H, Inoue T, Yoshida K et al (2007) Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1–T3 oral tongue cancer: influence of age on outcome. Anticancer Res 27:491–497PubMed
8.
Akiyama H, Yoshida K, Yamazaki H et al (2014) High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial. J Contemp Brachytherapy 1:10–14CrossRef
9.
Umeda M, Komatsubara H, Ojima Y et al (2005) A comparison of brachytherapy and surgery for the treatment of stage I–II squamous cell carcinoma of the tongue. Int J Oral Maxillofac Surg 34:739–744PubMedCrossRef
10.
Chakrabarti B, Ghorai S, Basu B et al (2010) Late nodal metastasis in early-stage node-negative oral cavity cancers after successful sole interstitial brachytherapy: an institutional experience of 42 cases in India. Brachytherapy 9:254–259PubMedCrossRef
11.
Matsumoto K, Sasaki T, Shioyama Y et al (2013) Treatment outcome of high-dose-rate interstitial radiation therapy for patients with stage I and II mobile tongue cancer. Jpn J Clin Oncol 43:1012–1017PubMedCrossRef
12.
Guinot JL, Arribas L, Tortajada MI et al (2013) From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: equivalent results but fewer complications. Brachytherapy 12:528–534PubMedCrossRef
13.
Serkies K, Ziemlewski A, Sawicki T et al (2013) Pulsed dose rate brachytherapy of lip cancer. J Contemp Brachytherapy 53:144–147CrossRef
14.
Rio E, Bardet E, Mervoyer A et al (2013) Interstitial brachytherapy for lower lip carcinoma: global assessment in a retrospective study of 89 cases. Head Neck 35:350–353PubMedCrossRef
15.
Ghadjar P, Bojaxhiu B, Simcock M et al (2012) High dose-rate versus low dose-rate brachytherapy for lip cancer. Int J Radiat Oncol Biol Phys 83:1205–1212PubMedCrossRef
16.
Martínez-Monge R, Cambeiro M, Moreno M et al (2011) Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 79:1158–1163PubMedCrossRef
17.
Teudt IU, Meyer JE, Ritter M et al (2014) Perioperative image-adapted brachytherapy for the treatment of paranasal sinus and nasal cavity malignancies. Brachytherapy 13:178–186PubMedCrossRef
18.
Martínez-Monge R, Gómez-Iturriaga A, Cambeiro M et al (2009) Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer. Brachytherapy 8:26–33PubMedCrossRef
19.
Teckie S, Scala LM, Ho F et al (2013) High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer. Brachytherapy 12:228–234PubMedCrossRef
20.
Nag S, Koc M, Schuller DE et al (2005) Intraoperative single fraction high dose-rate brachytherapy for head and neck cancers. Brachytherapy 4:217–223PubMedCrossRef
21.
Nag S, Tippin D, Grecula J et al (2004) Intraoperative high-dose-rate brachytherapy for paranasal sinus tumors. Int J Radiat Oncol Biol Phys 58:155–160PubMedCrossRef
22.
Perry DJ, Chan K, Wolden S et al (2010) High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys 76:1140–1146PubMedCrossRef
23.
Scala LM, Hu K, Urken ML et al (2013) Intraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer. Head Neck 35:485–492PubMedCrossRef
24.
Bartochowska A, Wierzbicka M, Skowronek J, Leszczyńska M, Szyfter W (2012) High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head and neck cancers. Brachytherapy 11:137–143PubMedCrossRef
25.
Strojan P, Corry J, Eisbruch A et al (2013) Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck. [Epub ahead of print]
26.
Strnad V, Lotter M, Kreppner S et al (2014) Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma. Brachytherapy 13:187–195PubMedCrossRef
27.
Rudzianskas V, Inciura A, Juozaityte E et al (2012) Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy. Acta Otorhinolaryngol Ital 32:297–303PubMedPubMedCentral
28.
Bartochowska A, Skowronek J, Wierzbicka M et al (2013) The role of high-dose-rate and pulsed-dose-rate brachytherapy in the management of recurrent or residual stomal tumor after total laryngectomy. Laryngoscope 123:657–661PubMedCrossRef
29.
Zhu L, Jiang Y, Wang J et al (2013) An investigation of 125I seed permanent implantation for recurrent carcinoma in the head and neck after surgery and external beam radiotherapy. World J Surg Oncol 11:60PubMedPubMedCentralCrossRef
30.
Tselis N, Ratka M, Vogt HG et al (2011) Hypofractionated accelerated CT-guided interstitial 192Ir-HDR-brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer. Radiother Oncol 98:57–62PubMedCrossRef
31.
Grimard L, Esche B, Lamothe A et al (2009) Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy. Brachytherapy 8:284–289PubMedCrossRef
32.
Gerbaulet A, Potter R, Mazeron J-J et al (2002) The GEC ESTRO handbook of brachytherapy. ESTRO, Brussels
33.
Schiefke F, Hildebrandt G, Pohlmann S et al (2008) Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas. J Craniomaxillofac Surg 36:285–292PubMedCrossRef
34.
Kakimoto N, Inoue T, Inoue T et al (2006) High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period. Anticancer Res 26:3933–3937PubMed
35.
Melzner WJ, Lotter M, Sauer R et al (2007) Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity? Radiother Oncol 82:167–173PubMedCrossRef
36.
Strnad V, Geiger M, Lotter M et al (2003) The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer. Brachytherapy 2:158–163PubMedCrossRef
37.
Peiffert D, Pernot M, Malissard L et al (1994) Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases. Int J Radiat Oncol Biol Phys 29:681–686PubMedCrossRef
38.
Kakimoto N, Inoue T, Inoue T et al (2003) Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer. Radiother Oncol 68:123–128PubMedCrossRef
39.
Ross DA, Hundal JS, Son YH et al (2004) Microsurgical free flap reconstruction outcomes in head and neck cancer patients after surgical extirpation and intraoperative brachytherapy. Laryngoscope 114:1170–1176PubMedCrossRef
40.
Do L, Puthawala A, Syed N (2009) Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer. Brachytherapy 8:385–391PubMedCrossRef
41.
Yoshimura R, Shibuya H, Miura M (2009) Quality of life of oral cancer patients after low-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 73:772–778PubMedCrossRef
42.
Nijdam WM, Levendag PC, Noever I et al (2008) Longitudinal changes in quality of life and costs in long-term survivors of tumors of the oropharynx treated with brachytherapy or surgery. Brachytherapy 7:343–350PubMedCrossRef
Metadaten
Titel
The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck
verfasst von
Małgorzata Wierzbicka
Anna Bartochowska
Vratislav Strnad
Primož Strojan
William M. Mendenhall
Louis B. Harrison
Alessandra Rinaldo
Puja Sahai
Susanne Wiegand
Alfio Ferlito
Publikationsdatum
01.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 2/2016
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-014-3332-8

Weitere Artikel der Ausgabe 2/2016

European Archives of Oto-Rhino-Laryngology 2/2016 Zur Ausgabe

Head and Neck

Detection of disseminated tumor cells in aspirative drains after neck dissection

Editorial

New editors in chief for the European Archives of Oto-Rhino-Laryngology

Letter to the Editor

Letter to the editor concerning: ‘Correlation between clinical findings and eosinophil/neutrophil ratio in patients with nasal polyps’

Laryngology

Comorbidities and factors associated with endoscopic surgical outcomes in adult laryngotracheal stenosis

Otology

The use of subtotal petrosectomy in cochlear implant candidates with chronic otitis media

Head and Neck

The incidence of thyroid cartilage invasion through the anterior commissure in clinically early-staged laryngeal cancer

Neu im Fachgebiet HNO

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise